PABCX
Price
$18.34
Change
+$0.08 (+0.44%)
Updated
Jun 30 closing price
Net Assets
1.01B
RLBBX
Price
$36.37
Change
+$0.16 (+0.44%)
Updated
Jun 30 closing price
Net Assets
250.05B
Interact to see
Advertisement

PABCX vs RLBBX

Header iconPABCX vs RLBBX Comparison
Open Charts PABCX vs RLBBXBanner chart's image
PGIM Balanced C
Price$18.34
Change+$0.08 (+0.44%)
VolumeN/A
Net Assets1.01B
American Funds American Balanced R2
Price$36.37
Change+$0.16 (+0.44%)
VolumeN/A
Net Assets250.05B
PABCX vs RLBBX Comparison Chart in %
Loading...
View a ticker or compare two or three
VS
PABCX vs. RLBBX commentary
Jul 01, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is PABCX is a StrongBuy and RLBBX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
RLBBX has more cash in the bank: 250B vs. PABCX (1.01B). PABCX pays higher dividends than RLBBX: PABCX (1.37) vs RLBBX (1.23). PABCX was incepted earlier than RLBBX: PABCX (29 years) vs RLBBX (23 years). PABCX (1.87) is less costly to investors than RLBBX (1.32). PABCX is a more actively managed with annual turnover of: 107.00 vs. RLBBX (44.00). RLBBX has a lower initial minimum investment than PABCX: RLBBX (250) vs PABCX (1000). RLBBX annual gain was more profitable for investors over the last year : 6.92 vs. PABCX (3.47). RLBBX return over 5 years is better than : 36.21 vs. PABCX (23.34).
PABCXRLBBXPABCX / RLBBX
Total Expense Ratio1.811.32137%
Annual Report Gross Expense Ratio1.871.32142%
Fund Existence29 years23 years-
Gain YTD5.1836.61478%
Front LoadN/AN/A-
Min. Initial Investment1000250400%
Min. Initial Investment IRAN/AN/A-
Net Assets1.01B250B0%
Annual Yield % from dividends1.371.23112%
Returns for 1 year3.476.9250%
Returns for 3 years27.5631.1788%
Returns for 5 years23.3436.2164%
Returns for 10 years27.8556.2250%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
OVID0.330.03
+9.24%
Ovid Therapeutics
PLYM16.060.21
+1.32%
Plymouth Industrial REIT
NWG14.150.10
+0.71%
NatWest Group plc
VSTM4.15N/A
N/A
Verastem
ORA83.76-0.39
-0.46%
Ormat Technologies